Luxturna gene therapy
Credit: OHSU News
Andreas Lauer, M.D., looks on as the Luxturna gene therapy treatment is prepared for injection into Caspian Soto's eye. Soto is among first in Oregon to have new treatment for rare, blindness-causing genetic mutation, September 17, 2018 at the OHSU Casey Eye Institute in Portland, Oregon. (OHSU/Kristyna Wentz-Graff)